Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models.

Saved in:
Bibliographic Details
Title: Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models.
Authors: Gruber DR; Pfizer, Inc., Bothell, Washington., Cummins EJ; Pfizer, Inc., Bothell, Washington., Zeng W; Pfizer, Inc., Bothell, Washington., Ulrich M; Pfizer, Inc., Bothell, Washington., Smith K; Pfizer, Inc., Bothell, Washington., Long M; Pfizer, Inc., Bothell, Washington., Spahr K; Pfizer, Inc., Bothell, Washington., Higgins S; Pfizer, Inc., Bothell, Washington., Hinricher K; Pfizer, Inc., Bothell, Washington., Langalia A; Pfizer, Inc., Bothell, Washington., Krumm K; Pfizer, Inc., Bothell, Washington., Olson DJ; Pfizer, Inc., Bothell, Washington., Grogan B; Pfizer, Inc., Bothell, Washington., Mazahreh R; Pfizer, Inc., Bothell, Washington., Gupta P; Pfizer, Inc., Bothell, Washington., Burke PJ; Pfizer, Inc., Bothell, Washington., Smith A; Pfizer, Inc., Bothell, Washington., Senter PD; Pfizer, Inc., Bothell, Washington., Gardai SJ; Pfizer, Inc., Bothell, Washington., Hill AG; Pfizer, Inc., Bothell, Washington., Gray EE; Pfizer, Inc., Bothell, Washington.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2026 Mar 02; Vol. 25 (3), pp. 457-468.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-8514
DOI:10.1158/1535-7163.MCT-25-0108